Pacific Biosciences Of California (PACB)
Cost of Revenue
$101.98M
TTM · Period ending: · USD
PACB Cost of Revenue
Latest reported$101.98Mperiod ending
Latest reported$101.98Mperiod ending
PACB TTM Cost of Revenue ($0.00 → $101.98M)
TTM cost of revenue
High-resolution chart · PNG
PACB cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 101,975,000 | |
| 100,688,000 | |
| 114,875,000 | |
| 116,145,000 | |
| 122,735,000 | |
| 127,728,000 | |
| 116,732,000 | |
| 136,352,000 | |
| 144,178,000 | |
| 146,130,000 | |
| 147,741,000 | |
| 121,168,000 | |
| 102,143,000 | |
| 89,390,000 | |
| 79,269,000 | |
| 76,309,000 | |
| 77,068,000 | |
| 74,651,000 | |
| 71,653,000 | |
| 68,135,000 | |
| 60,630,000 | |
| 54,237,000 | |
| 46,327,000 | |
| 45,590,000 | |
| 48,573,000 | |
| 53,117,000 | |
| 56,315,000 | |
| 55,097,000 | |
| 55,064,000 | |
| 52,772,000 | |
| 53,530,000 | |
| 55,191,000 | |
| 55,541,000 | |
| 54,897,000 | |
| 58,809,000 | |
| 57,716,000 | |
| 54,878,000 | |
| 52,909,000 | |
| 46,554,000 | |
| 42,021,000 | |
| 36,907,000 | |
| 37,237,000 | |
| 39,332,000 | |
| 41,983,000 | |
| 42,078,000 | |
| 39,944,000 | |
| 37,192,000 | |
| 30,671,000 | |
| 29,390,000 | |
| 26,080,000 | |
| 21,762,000 | |
| 21,068,000 | |
| 17,474,000 | |
| 19,501,000 | |
| 25,043,000 | |
| 30,699,000 | |
| 35,304,000 | |
| 31,019,000 | |
| 20,829,000 | |
| 9,922,000 | |
| 2,731,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |